Progyny, Inc. Announces Details for Its Third Quarter 2022 Results Report
Progyny, Inc. (Nasdaq: PGNY) will report its financial results for Q3 2022 on November 3, 2022, after market close. A conference call will follow at 4:45 P.M. ET, accessible via dialing 1-866-825-7331 (U.S.) or 1-973-413-6106 (international) with passcode 265484. An audio replay will be available until November 10, 2022. Progyny specializes in fertility benefits management, aiming to improve patient outcomes and reduce employer costs. The company has received multiple accolades, including recognition from CNBC Disruptor 50 and Modern Healthcare.
- Upcoming financial results may provide insights on company growth.
- Recognition from notable entities indicates industry leadership.
- None.
NEW YORK, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility and family building benefits solutions, will report its financial results for the quarterly period ended September 30, 2022 after the close of the market on Thursday, November 3, 2022.
The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Thursday, November 10, 2022 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a leading fertility benefits management company. We are redefining fertility and family building benefits, proving that a comprehensive and inclusive solution can simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with education and guidance from a dedicated Patient Care Advocate (PCA), provides access to a premier network of fertility specialists using the latest science and technologies, reduces healthcare costs for the nation’s leading employers, and drives optimal clinical outcomes. We envision a world where anyone who wants to have a child can do so.
Headquartered in New York City, Progyny has been recognized for its leadership and growth by CNBC Disruptor 50, Modern Healthcare’s Best Places to Work in Healthcare, Financial Times, INC. 5000, and Crain’s Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Selena Yang
media@progyny.com
FAQ
When will Progyny report its financial results for Q3 2022?
What time is the Progyny conference call on November 3, 2022?
How can I join the Progyny Q3 2022 financial results call?
What is Progyny's focus area?
